NASDAQ
Coherus Oncology, Inc. (CHRS) has a fcf yield of -81.04% as of Friday, May 29, 2026. This represents a 190.56% decrease compared to its 12-month average of -27.89%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.